Direct medical costs associated with the extrahepatic manifestations of hepatitis C virus infection in France

ConclusionExtrahepatic manifestations of HCV infection substantially add to the overall economic burden of the disease in France. HCV cure after anti‐viral therapy is expected to significantly reduce the total costs of managing these manifestations in France.
Source: Alimentary Pharmacology and Therapeutics - Category: Drugs & Pharmacology Authors: Tags: ORIGINAL ARTICLE Source Type: research

Related Links:

More News: Databases & Libraries | Diabetes | Drugs & Pharmacology | Endocrinology | France Health | Healthcare Costs | Heart Attack | Hepatitis | Hepatitis C | Stroke | Vasculitis